跳至主要内容
临床试验/NL-OMON56464
NL-OMON56464招募中不适用

Phenotyping and classifying of childhood and adult asthma exacerbations: towards future personalised treatment. An observational multicentre study. - ExCluSie-F study

Franciscus Gasthuis & Vlietland0 个研究点目标入组 200 人开始时间: 待定最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
200

研究概览

简要总结

暂无简介。

研究设计

研究类型
Observational

入排标准

年龄范围
12 至 99(—)

入选标准

  • - Patients between 12 and 70 years old, diagnosed with asthma according to the
  • GINA guidelines. If patients are doctor*s diagnosed with asthma based on
  • clinical data, the further diagnostics will be performed to confirm the
  • diagnosis after the AAE.
  • - Mild to severe asthma, treated according to GINA guidelines with medium - or
  • high dose inhaled corticosteroids (with or without LABA) or treated with a low
  • dose inhaled corticosteroids combined LABA or leukotriene - receptor
  • antagonist.
  • - Asthma exacerbation, indication for systemic corticosteroids.
  • - Written personal and/or parental informed consent, prior to any study
  • procedures.
  • - Eligibility and willingness to present during an asthma exacerbation at the
  • Franciscus Gasthuis hospital.
  • - Ability to use e - health applications.

排除标准

  • - Immunosuppressive maintenance medication (azithromycin, systemic
  • corticosteroids maintenance therapy and other) or recently (< 6 weeks)
  • discontinued these medications. (Desensitization therapy indicated for
  • allergies can be included in the study)
  • - Maintenance medication or recently discontinued (< 6 weeks) biologicals.
  • - Other underlying inflammatory or auto-immune diseases, such as rheumatologic
  • - Involvement in the planning and/or conduct of the study (applies to both
  • investigator staff and/or staff at the study site)
  • - Pregnancy, because of the possible altered immunological status.(31)
  • - Participation in an interventional study or randomised controlled trial.

研究者

相似试验